Difference in the Inhibitory Effect of Temozolomide on TJ905 Glioma Cells and Stem Cells

This study aims to determine the difference in the inhibitory effect of temozolomide (TMZ) on TJ905 glioma cells and stem cells. TJ905 cancer stem cells were isolated. Livin is a member of the inhibitor of apoptosis protein family. The TJ905 cells and cancer stem cells were transfected with a Livin-shRNA and negative-shRNA, respectively, and then treated with TMZ. At 48 h post-transfection, a cell counting kit 8 assay, flow cytometry, and real-time qPCR were performed to detect cell proliferation, the cell cycle, and the expression of the Caspase-3, -7, and -9 mRNAs, respectively. As a result, the suppressive effect of TMZ on TJ905 cells was more significant than its effect on TJ905 cancer stem cells. TMZ exerted an inhibitory effect on the growth of TJ905 glioma cells by arresting them at G0/G1 phase and arresting cancer stem cells at S phase in a dose-dependent manner. TMZ inhibited Livin mRNA expression and increased the expression of the Caspase-3, -7, and -9 mRNAs. Low Livin mRNA expression induced high levels of Caspase-3, -7, and -9 expressions, thus promoting the apoptosis of both TJ905 cells and cancer stem cells in response to TMZ treatment. The TJ905 cells transfected with the Livin-shRNA were more sensitive to TMZ, whereas the TJ905 glioma stem cells transfected with the Livin-shRNA showed no significant changes in their sensitivity to TMZ. In conclusion, the Livin gene may play an important role in the resistance mechanisms of TJ905 glioma cells and cancer stem cells. However, Livin had a more distinct role in TMZ resistance, cell proliferation, and the cell cycle in TJ905 glioma cells than in cancer stem cells..

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:8

Enthalten in:

Frontiers in Neurology - 8(2017)

Sprache:

Englisch

Beteiligte Personen:

Feng Jin [VerfasserIn]
Guang-Kui Han [VerfasserIn]
Hao Zhang [VerfasserIn]
Ran Zhang [VerfasserIn]
Gen-Hua Li [VerfasserIn]
Song Feng [VerfasserIn]
Xian-Yun Qin [VerfasserIn]
Ling-Sheng Kong [VerfasserIn]
Quan-Min Nie [VerfasserIn]
Hua-Rong Li [VerfasserIn]
Lei Zhao [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
journal.frontiersin.org [kostenfrei]
Journal toc [kostenfrei]

Themen:

Cancer stem cells
Glioma
Livin
Neurology. Diseases of the nervous system
Proliferation
Temozolomide

doi:

10.3389/fneur.2017.00474

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ002159201